Identification of JAK2 as a mediator of FIP1L1-PDGFRA-induced eosinophil growth and function in CEL
about
Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis.Alterations in polyadenylation and its implications for endocrine disease.Complex hypereosinophilia arising from post-polycythemia vera myelofibrosis: A case of imatinib-responsiveness.World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.Hematopoietic stem cells, progenitor cells and leukemic stem cells in adult myeloproliferative neoplasms.Signaling pathways in lymphoma: pathogenesis and therapeutic targets.STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis.World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemia.Epstein-Barr Virus-induced Gene 2 Mediates Allergen-induced Leukocyte Migration into Airways.Leukemogenic kinase FIP1L1-PDGFRA and a small ubiquitin-like modifier E3 ligase, PIAS1, form a positive cross-talk through their enzymatic activitiesLyn mediates FIP1L1-PDGFRA signal pathway facilitating IL-5RA intracellular signal through FIP1L1-PDGFRA/JAK2/Lyn/Akt network complex in CEL.The oncogenic FIP1L1-PDGFRα fusion protein displays skewed signaling properties compared to its wild-type PDGFRα counterpart.World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.First report of FIP1L1-PDGFRα-positive eosinophilic granulomatosis with polyangiitis.Involvement of nuclear JAK2 signaling in AG490-induced apoptosis of gastric cancer cells.
P2860
Q34495630-B6359546-7A47-4385-BB6D-6C4460586BCEQ36824347-99B7B99C-D017-4F62-890D-7A3F9D447CEDQ37209121-BBB43E9B-FC49-425F-8F0E-08FE15F504ECQ38038509-ADE5DA56-F5EF-4082-AB0F-E241370B7F8AQ38046648-90A25A39-9194-4D65-8F7C-F442074F16ACQ38150876-0A88483A-6D98-4E4E-A491-EE696EF85C8EQ38177821-940C0A56-F1F8-4124-89C6-4BCF604F7A75Q38191834-E466A414-2712-435B-995F-3E104C19DF7EQ39159911-6C364ECE-8FEB-4AF4-B0E5-0289699E8EFDQ40363493-85F07154-E413-4450-B943-A78CB93B97A5Q41786014-EF66499B-52F8-4F5D-9493-F1056472484AQ42371492-9DC09CF6-DE71-40C7-A320-BF514B86C848Q42586449-2956E340-76A4-4002-9EC3-D0E2708CF539Q46026437-8877BE71-5CD6-4EC6-80D0-63FCF5A958E8Q52935364-DB9E4BE5-03AA-4457-A446-55DD7FB9175CQ54401314-4F58589C-FFB7-4462-B0C5-96A2EA584DC5
P2860
Identification of JAK2 as a mediator of FIP1L1-PDGFRA-induced eosinophil growth and function in CEL
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Identification of JAK2 as a me ...... hil growth and function in CEL
@ast
Identification of JAK2 as a me ...... hil growth and function in CEL
@en
Identification of JAK2 as a me ...... hil growth and function in CEL
@nl
type
label
Identification of JAK2 as a me ...... hil growth and function in CEL
@ast
Identification of JAK2 as a me ...... hil growth and function in CEL
@en
Identification of JAK2 as a me ...... hil growth and function in CEL
@nl
prefLabel
Identification of JAK2 as a me ...... hil growth and function in CEL
@ast
Identification of JAK2 as a me ...... hil growth and function in CEL
@en
Identification of JAK2 as a me ...... hil growth and function in CEL
@nl
P2093
P2860
P1433
P1476
Identification of JAK2 as a me ...... hil growth and function in CEL
@en
P2093
Chaojun Duan
Chunfang Zhang
Faqing Tang
Guangsen Zhang
Jingchen Lu
Ruijuan Li
Xinying Li
P2860
P304
P356
10.1371/JOURNAL.PONE.0034912
P407
P577
2012-04-16T00:00:00Z